Mkts

NewAmsterdam Pharma Company N.V.

NASDAQ: NAMS
$19.71-1.87 (-8.67%)
As of Oct 23, 4:00 PM ET

Key statistics

Day range
19.1321.39
52-week range
19.5842.20
Today
Open21.39
Previous close19.71
Volume—
Valuation
Market cap2.58B
P/E ratio—
EPS (TTM)-2.15
Income & risk
Dividend / yield—
Beta0.11
Avg volume1.32M
Discussion

NAMS News

Stories mentioning NAMS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue3,04032.00348.0019,1452,97812,77229,1112,279
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development38,00938,59430,97127,51644,75134,89535,70238,379
Sales General & Admin23,45127,41824,52027,26427,15221,10618,41216,475
Total Operating Expenses61,46066,01255,49154,78071,90356,00154,11454,854
Operating Income (Loss)(58,420)(65,980)(55,143)(35,635)(68,925)(43,229)(25,003)(52,575)
Interest Income5,6506,4736,7137,0557,3514,4854,4434,870
Interest Expense
Other Expense
Pretax Income(48,441)(74,923)(72,005)(17,364)(39,527)(92,177)(16,648)(39,007)
Tax Provision(1.00)
Net Income (Loss)(48,441)(74,923)(72,005)(17,364)(39,527)(92,177)(16,647)(39,007)
Earnings Per Share (Basic)(0.40)(0.63)(0.61)(0.15)(0.34)(0.98)(0.18)(0.41)
Earnings Per Share (Diluted)(0.40)(0.63)(0.61)(0.15)(0.34)(0.98)(0.18)(0.41)
Weighted Average Shares Outstanding (Basic)121,716118,424119,000118,556116,12594,35894,75494,712
Weighted Average Shares Outstanding (Diluted)121,716118,424119,000118,556116,12594,35894,75494,712

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About NAMS

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is a stock listed on the Nasdaq Stock Market under the ticker symbol NAMS. It last traded at $19.71 (Oct 23, 2026, 4:00 PM ET), down 8.7% on the day. That gives NewAmsterdam Pharma a market capitalisation of $2.6B.

Over the past 52 weeks NAMS has traded between $19.58 and $42.20.

Revenue for the quarter ended Mar 31, 2026 was $3.0M; a net loss of $48.4M. Revenue was up 2.1% from $3.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$3.0M-$48.4M-1593.5%
Dec 31, 2025$32.0K-$74.9M-234134.4%
Sep 30, 2025$348.0K-$72.0M-20691.1%
Jun 30, 2025$19.1M-$17.4M-90.7%

From NewAmsterdam Pharma’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…